| Literature DB >> 24892430 |
Tsung-Chieh Yao1, Yu-Ling Tu2, Su-Wei Chang3, Hui-Ju Tsai4, Po-Wen Gu5, Hsian-Chen Ning5, Man-Chin Hua6, Sui-Ling Liao6, Ming-Han Tsai6, Chih-Yung Chiu6, Shen-Hao Lai7, Kuo-Wei Yeh1, Jing-Long Huang1, Jing-Long Huang1.
Abstract
BACKGROUND: New evidence shows high prevalence of vitamin D deficiency in many countries and some studies suggest a possible link between vitamin D status and allergic diseases. The objectives of this study were to determine the prevalence of suboptimal vitamin D status in a population sample of Asian children and to investigate the relationship of vitamin D status with allergic diseases and atopy.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24892430 PMCID: PMC4043968 DOI: 10.1371/journal.pone.0099105
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Schematic presentation of the recruitment process of the study subjects.
Characteristics of 1315 subjects according to serum 25(OH)D levels.
| Serum 25(OH)D level | |||||
| Characteristic | All (N = 1315) | <20 ng/mL (n = 670) | 20–29.9 ng/mL (n = 517) | ≧30 ng/mL (n = 128) |
|
|
| 10.3±2.7 | 10.9±2.6 | 9.7±2.5 | 9.5±2.8 |
|
|
| |||||
|
| 645 (49.0) | 274 (42.5) | 294 (45.6) | 77 (11.9) |
|
|
| 670 (51.0) | 396 (59.1) | 223 (33.3) | 51 (7.6) | |
|
| 18.7±3.6 | 19.1±3.8 | 18.4±3.4 | 17.6±2.9 |
|
|
| |||||
|
| 586 (44.6) | 340 (58.0) | 207 (35.3) | 39 (6.7) |
|
|
| 206 (15.7) | 53 (25.7) | 118 (57.3) | 35 (17.0) | |
|
| 85 (6.5) | 28 (32.9) | 48 (56.5) | 9 (10.6) | |
|
| 438 (33.3) | 249 (56.8) | 144 (32.9) | 45 (10.3) | |
|
| |||||
|
| 517 (40.6) | 271 (52.4) | 196 (37.9) | 50 (9.7) | 0.572 |
|
| 755 (59.4) | 373 (49.4) | 304 (40.3) | 78 (10.3) | |
|
| |||||
|
| 9 (0.7) | 5 (55.6) | 2 (22.2) | 2 (22.2) | 0.339 |
|
| 1306 (99.3) | 665 (50.9) | 515 (39.4) | 126 (9.6) | |
|
| |||||
|
| 692 (54.1) | 368 (53.2) | 271 (39.2) | 53 (7.7) |
|
|
| 586 (45.9) | 278 (47.4) | 233 (39.8) | 75 (12.8) | |
|
| |||||
|
| 80 (6.3) | 35 (43.8) | 39 (48.8) | 6 (7.5) | 0.214 |
|
| 1190 (93.7) | 605 (50.8) | 464 (39.0) | 121 (10.2) | |
25(OH)D, 25-hydroxyvitamin D; BMI, body mass index; URI, upper respiratory infection.
Figure 2Serum 25(OH)D levels: (a) histogram, (b) distribution.
Figure 3Serum 25(OH)D levels by (a) age (r = −0.273, P<0.001), (b) body mass index (r = −0.179, P<0.001), and (c) gender (P<0.001), season of sampling (P<0.001), and passive smoking (P = 0.003).
Multivariate linear regression analyses for serum 25(OH)D levels.
| Variable | Coefficient (95% CI) |
|
|
| −0.025 (−0.033∼−0.017) |
|
|
| 0.120 (0.080∼0.160) |
|
|
| −0.010 (−0.016∼−0.004) |
|
|
| ||
|
| −0.214 (−0.273∼−0.154) |
|
|
| Reference | - |
|
| −0.046 (−0.138∼0.046) | 0.322 |
|
| −0.183 (−0.245∼−0.120) |
|
|
| −0.051 (−0.091∼−0.012) |
|
25(OH)D, 25-hydroxyvitamin D; BMI, body mass index.
Multivariate ordinal logistic regression analyses for categories of serum 25(OH)D levels*.
| Variable | OR (95% CI) |
|
|
| 0.89 (0.85∼0.94) |
|
|
| 1.97 (1.58∼2.47) |
|
|
| 0.96 (0.93∼0.99) |
|
|
| ||
|
| 0.36 (0.26∼0.50) |
|
|
| 1.00 (Reference) | - |
|
| 0.79 (0.49∼1.30) | 0.354 |
|
| 0.42 (0.30∼0.59) |
|
|
| 0.76 (0.61∼0.95) |
|
25(OH)D, 25-hydroxyvitamin D; OR, odds ratio; BMI, body mass index.
*Serum 25(OH)D levels were categorized into 3 ordinal categories of vitamin D status: <20, 20–29.9, and ≧30 ng/mL. The reference group for each variable is given in parentheses. The interpretation of the ORs from the ordinal logistic models is similar to the interpretation of the ORs in the binary logistic regression. For example, the OR for "male subjects (compared with female subjects)" is 1.97, which means that for male subjects, the odds of being in the ≧30 versus the <30 ng/mL category are 1.97 times the odds for female subjects, assuming that all other variables in the model are held constant. Likewise, the odds are the same for the comparison of the ≧20 versus the <20 ng/mL category (on the basis of confirmed proportional odds assumption).
Association of serum 25(OH)D status with allergic diseases and atopy.
| Unadjusted | Adjusted | ||||
| Subjects n/N (%) | OR (95% CI) |
| OR (95% CI) |
| |
|
| |||||
| ≧30 ng/mL | 4/127 (3.1) | 1.00 (Reference) | - | 1.00 (Reference) | - |
| 20–29.9 ng/mL | 24/509 (4.7) | 1.52 (0.52∼4.47) | 0.445 | 1.48 (0.50∼4.39) | 0.481 |
| <20 ng/mL | 31/656 (4.7) | 1.53 (0.53∼4.40) | 0.435 | 1.74 (0.58∼5.17) | 0.322 |
|
| |||||
| ≧30 ng/mL | 41/122 (33.6) | 1.00 (Reference) | - | 1.00 (Reference) | - |
| 20–29.9 ng/mL | 156/508 (30.7) | 0.88 (0.58∼1.33) | 0.535 | 0.93 (0.60∼1.43) | 0.736 |
| <20 ng/mL | 181/647 (28.0) | 0.77 (0.51∼1.16) | 0.209 | 0.93 (0.60∼1.44) | 0.737 |
|
| |||||
| ≧30 ng/mL | 9/126 (7.1) | 1.00 (Reference) | - | 1.00 (Reference) | - |
| 20–29.9 ng/mL | 43/504 (8.5) | 1.21 (0.58∼2.56) | 0.613 | 1.28 (0.60∼2.74) | 0.522 |
| <20 ng/mL | 35/648 (5.4) | 0.74 (0.35∼1.59) | 0.441 | 0.92 (0.42∼2.04) | 0.836 |
|
| |||||
| ≧30 ng/mL | 75/128 (58.6) | 1.00 (Reference) | - | 1.00 (Reference) | - |
| 20–29.9 ng/mL | 309/515 (60.0) | 1.06 (0.72∼1.57) | 0.772 | 1.07 (0.72∼1.60) | 0.734 |
| <20 ng/mL | 365/668 (54.6) | 0.85 (0.58∼1.25) | 0.410 | 0.92 (0.62∼1.38) | 0.689 |
25(OH)D, 25-hydroxyvitamin D; OR, odds ratio; CI, confidence interval.
*N is the sample size of each category of serum 25(OH)D and n is the number of cases in each category.
**Adjusted for age, gender, body mass index, season of sampling, and passive smoking.
Association of serum 25(OH)D status with total immunoglobulin E levels.
| Unadjusted | Adjusted | ||||
| 25(OH)D (ng/mL) | Subjects | Coefficient (95% CI) |
| Coefficient (95% CI) |
|
| ≧30 ng/mL | 128 | Reference | - | Reference | - |
| 20–29.9 ng/mL | 515 | 0.159 (−0.153∼0.471) | 0.319 | 0.161 (−0.155∼0.476) | 0.317 |
| <20 ng/mL | 668 | 0.076 (−0.229∼0.381) | 0.624 | 0.116 (−0.198∼0.431) | 0.468 |
25(OH)D, 25-hydroxyvitamin D; CI, confidence interval.
Total immunoglobulin E levels were logarithmically transformed for analysis.
*Adjusted for age, gender, body mass index, season of sampling, and passive smoking.